These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18752758)

  • 41. [Effect of isosorbide-5-mononitrate, metipranolol and a combination of the two in experimental myocardial ischemia in the awake dog].
    Sponer G; Voss E; Dietmann K
    Med Welt; 1981 Apr; 32(14A):492-6. PubMed ID: 6113532
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevention of varices rebleeding: are drugs better after all?
    Blendis L; Wong F
    Gastroenterology; 2002 Mar; 122(3):832-3. PubMed ID: 11875021
    [No Abstract]   [Full Text] [Related]  

  • 43. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence.
    Kumar A; Jha SK; Sharma P; Dubey S; Tyagi P; Sharma BC; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):892-901, 901.e1. PubMed ID: 19481079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
    Bai M; Qi X; Yang M; Han G; Fan D
    J Gastroenterol Hepatol; 2014 Mar; 29(3):442-52. PubMed ID: 24118091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
    Uusitalo A
    Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological therapy for portal hypertension: rationale and results.
    Burroughs AK; Panagou E
    Semin Gastrointest Dis; 1995 Jul; 6(3):148-64. PubMed ID: 7551972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
    Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of a combined treatment with propranolol and isosorbide-5-mononitrate on Doppler ultrasound parameters in patients with cirrhosis and portal hypertension.
    Orban Schiopu AM; Balas BI; Diculescu M
    Rom J Gastroenterol; 2005 Jun; 14(2):123-7. PubMed ID: 15990930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevention of variceal bleeding and measurement of hepatic vein pressure gradient].
    Youn KH; Kim DJ
    Korean J Hepatol; 2006 Sep; 12(3):464-8. PubMed ID: 16998301
    [No Abstract]   [Full Text] [Related]  

  • 50. Endoscopic variceal pressure measurements: response to isosorbide dinitrate.
    Dawson J; Gertsch P; Mosimann F; West R; Elias E
    Gut; 1985 Aug; 26(8):843-7. PubMed ID: 4018651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The randomized controlled trial of isosorbide mononitrate plus propranolol compared with propranolol alone for the prevention of variceal rebleeding].
    Zhang Q; Yuan R; Wang H
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1157-9. PubMed ID: 12475399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial.
    Lo GH; Lai KH; Cheng JS; Chen MH; Huang HC; Hsu PI; Lin CK
    Hepatology; 2000 Sep; 32(3):461-5. PubMed ID: 10960435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimal use of propranolol.
    Mann NS
    Gastroenterology; 2003 Jun; 124(7):2005. PubMed ID: 12812199
    [No Abstract]   [Full Text] [Related]  

  • 54. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
    J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secondary prophylaxis for esophageal variceal bleeding.
    Albillos A; Tejedor M
    Clin Liver Dis; 2014 May; 18(2):359-70. PubMed ID: 24679500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. GTIP Gruppo Triveneto per l'Ipertensione Portale.
    Merkel C; Gatta A; Donada C; Enzo E; Marin R; Amodio P; Torboli P; Angeli P; Cavallarin G; Sebastianelli G
    Hepatology; 1995 Sep; 22(3):808-13. PubMed ID: 7657286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current endoscopic therapy of variceal bleeding.
    Villanueva C; Colomo A; Aracil C; Guarner C
    Best Pract Res Clin Gastroenterol; 2008; 22(2):261-78. PubMed ID: 18346683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding.
    Stanley AJ; Dickson S; Hayes PC; Forrest EH; Mills PR; Tripathi D; Leithead JA; MacBeth K; Smith L; Gaya DR; Suzuki H; Young D
    J Hepatol; 2014 Nov; 61(5):1014-9. PubMed ID: 24953021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variceal bleeding and portal hypertension: still a therapeutic challenge?
    Seewald S; Seitz U; Yang AM; Soehendra N
    Endoscopy; 2001 Feb; 33(2):126-39. PubMed ID: 11272215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy of portal hypertension].
    Fleig WE
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():46-7. PubMed ID: 12467008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.